The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand
出版年份 2017 全文链接
标题
The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 25, Pages 10390-10397
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2017-05-06
DOI
10.1074/jbc.m117.786830
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- The AS‐RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation
- (2016) Ngoc‐Tung Tran et al. EMBO REPORTS
- A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer
- (2015) L. Bergmann et al. EUROPEAN JOURNAL OF CANCER
- Immunotherapy improves overall survival in pancreatic cancer
- (2015) Susan Mayor LANCET ONCOLOGY
- MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC
- (2015) Pooja Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer
- (2015) Kaiyu Yuan et al. Oncotarget
- Activation of AKT by O-Linked N-Acetylglucosamine Induces Vascular Calcification in Diabetes Mellitus
- (2014) Jack M. Heath et al. CIRCULATION RESEARCH
- Photothermal Treatment of Human Pancreatic Cancer Using PEGylated Multi-Walled Carbon Nanotubes Induces Apoptosis by Triggering Mitochondrial Membrane Depolarization Mechanism
- (2014) Teodora Mocan et al. Journal of Cancer
- Regulation of metabolism by long, non-coding RNAs
- (2014) Jan-Wilhelm Kornfeld et al. Frontiers in Genetics
- PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy
- (2013) K. Yuan et al. CLINICAL CANCER RESEARCH
- A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
- (2012) H. L. Kindler et al. ANNALS OF ONCOLOGY
- Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification
- (2012) Yong Sun et al. CIRCULATION RESEARCH
- TRAIL: A Sword for Killing Tumors
- (2012) S. Wang CURRENT MEDICINAL CHEMISTRY
- Serum response factor regulates bone formation via IGF-1 and Runx2 signals
- (2012) Jianfeng Chen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
- (2012) A. Avan et al. MOLECULAR CANCER THERAPEUTICS
- HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
- (2012) K Kim et al. ONCOGENE
- On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
- (2012) L Y Dimberg et al. ONCOGENE
- Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages
- (2011) Chang Hyun Byon et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
- (2011) R. Kogo et al. CANCER RESEARCH
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- Non-coding RNAs in human disease
- (2011) Manel Esteller NATURE REVIEWS GENETICS
- MicroRNAs: miRRORS of health and disease
- (2011) Monty Montano Translational Research
- A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
- (2010) A Younes et al. BRITISH JOURNAL OF CANCER
- Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
- (2010) Andres Forero-Torres et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Death Receptor Agonists as a Targeted Therapy for Cancer
- (2010) J. Wiezorek et al. CLINICAL CANCER RESEARCH
- A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
- (2010) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Large non-coding RNAs: missing links in cancer?
- (2010) M. Huarte et al. HUMAN MOLECULAR GENETICS
- A Combination of DR5 Agonistic Monoclonal Antibody with Gemcitabine Targets Pancreatic Cancer Stem Cells and Results in Long-term Disease Control in Human Pancreatic Cancer Model
- (2010) N. V. Rajeshkumar et al. MOLECULAR CANCER THERAPEUTICS
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
- (2010) M.-C. Tsai et al. SCIENCE
- TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
- (2009) Peter A. Holoch et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Regulation of TNFR1 and CD95 signalling by receptor compartmentalization
- (2008) Stefan Schütze et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Small non-coding RNAs in animal development
- (2008) Giovanni Stefani et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search